發(fā)布時(shí)間：2019-06-09 18:26

【摘要】：線粒體鈣穩(wěn)態(tài)對(duì)線粒體功能及細(xì)胞的影響至關(guān)重要,線粒體鈣維持胞漿鈣離子濃度動(dòng)態(tài)平衡,是線粒體呼吸功能的重要調(diào)節(jié)因素,鈣離子失衡導(dǎo)致細(xì)胞凋亡。線粒體鈣穩(wěn)態(tài)重塑是多種疾病發(fā)生的主要原因,但這一改變是否在腫瘤惡性進(jìn)展中發(fā)揮關(guān)鍵作用尚無明確報(bào)道。我們的研究團(tuán)隊(duì)首次發(fā)現(xiàn):新近報(bào)道的線粒體鈣離子攝取關(guān)鍵調(diào)節(jié)分子MCUR1,促進(jìn)肝癌細(xì)胞粒體鈣穩(wěn)態(tài)攝取,其表達(dá)水平在肝癌組織細(xì)胞中異常升高,MCUR1高表達(dá)能夠通過加速細(xì)胞增殖抑制線粒體依賴的內(nèi)源性細(xì)胞凋亡而促進(jìn)了肝癌細(xì)胞的生長能力,并且與肝癌病人的不良預(yù)后相關(guān)。文獻(xiàn)報(bào)道,線粒體的鈣離子環(huán)境是調(diào)控細(xì)胞活性氧ROS生成的關(guān)鍵因素,而活性氧ROS作為胞內(nèi)重要的第二信使,能夠激活包括與腫瘤細(xì)胞增殖,凋亡,轉(zhuǎn)移與腫瘤細(xì)胞的血管生成相關(guān)的多種關(guān)鍵信號(hào)通路,最終導(dǎo)致惡性腫瘤發(fā)生。我們進(jìn)一步研究發(fā)現(xiàn)MCUR1介導(dǎo)的線粒體鈣穩(wěn)態(tài)重塑導(dǎo)致肝癌細(xì)胞活性氧ROS水平上調(diào),這一改變與其下游P53降解,AKT/MDM2信號(hào)通路活化密切相關(guān)。基于此,我們提出假說:MCUR1上調(diào)引發(fā)線粒體鈣穩(wěn)態(tài)重塑,通過調(diào)控胞內(nèi)第二信使ROS生成影響其下游akt/mdm2介導(dǎo)的p53降解信號(hào)通路,最終促進(jìn)肝癌的惡性進(jìn)展。【目的】本課題以肝癌為研究對(duì)象,選擇線粒體鈣離子攝取關(guān)鍵調(diào)節(jié)分子mcur1,明確mcur1介導(dǎo)的線粒體鈣穩(wěn)態(tài)重塑是否參與對(duì)肝癌生長的調(diào)控,并探索mcur1介導(dǎo)的線粒體鈣穩(wěn)態(tài)重塑調(diào)控肝癌生長的作用機(jī)制。【方法】1.利用免疫組化實(shí)驗(yàn)分析mcur1以及p53在原發(fā)性肝癌臨床標(biāo)本的表達(dá)及相關(guān)性。2.利用mts法測(cè)定細(xì)胞生長曲線、克隆形成實(shí)驗(yàn)、annexin-v凋亡檢測(cè)、流式細(xì)胞周期檢測(cè)、edu細(xì)胞增殖等實(shí)驗(yàn)方法,分析mcur1對(duì)肝癌細(xì)胞增殖凋亡及生長的影響。3.利用裸鼠皮下荷瘤實(shí)驗(yàn),分析mcur1在體內(nèi)對(duì)肝癌生長的影響。4.利用rhod-2,fluo-4活細(xì)胞染色,分析mcur1對(duì)肝癌細(xì)胞線粒體基礎(chǔ)鈣離子水平以及線粒體對(duì)胞漿鈣的緩沖作用的影響。5.利用dcf及mitosox染料對(duì)細(xì)胞ros及線粒體ros進(jìn)行染色,分析mcur1對(duì)肝癌細(xì)胞線粒體ros生成的影響。6.利用westernblot檢測(cè)凋亡相關(guān)分子,以及增殖相關(guān)分子的表達(dá)改變,分析mcur1介導(dǎo)的線粒體鈣穩(wěn)態(tài)重塑促進(jìn)肝癌細(xì)胞的生長的作用機(jī)制�！窘Y(jié)果】第一部分:通過對(duì)原發(fā)性肝癌臨床標(biāo)本進(jìn)行分析,發(fā)現(xiàn)mcur1在肝癌組織中表達(dá)上調(diào),與肝癌不良預(yù)后相關(guān)。通過采用mts法測(cè)定細(xì)胞生長曲線、克隆形成實(shí)驗(yàn)、annexin-v凋亡檢測(cè)、流式細(xì)胞周期檢測(cè)、edu細(xì)胞增殖等實(shí)驗(yàn)方法,發(fā)現(xiàn)肝癌細(xì)胞中mcur1通過抑制細(xì)胞凋亡并且加速細(xì)胞增殖而促進(jìn)肝癌細(xì)胞的生長。通過進(jìn)行裸鼠皮下荷瘤實(shí)驗(yàn),證實(shí)mcur1通過抑制肝癌凋亡,加速肝癌增殖,而促進(jìn)肝癌的生長。第二部分:通過rhod-2,fluo-4染色檢測(cè)線粒體鈣以及胞漿鈣,發(fā)現(xiàn):mcur1能夠促進(jìn)線粒體鈣離子攝入,提升線粒體基礎(chǔ)鈣離子濃度,并且在應(yīng)急狀態(tài)下線粒體對(duì)胞漿鈣的緩沖力。通過對(duì)線粒體單向轉(zhuǎn)運(yùn)體mcu進(jìn)行干預(yù)處理,發(fā)現(xiàn)mcur1依賴于mcu促進(jìn)肝癌細(xì)胞線粒體鈣的攝取。第三部分:通過對(duì)細(xì)胞ROS以及線粒體ROS的檢測(cè),發(fā)現(xiàn)MCUR1能夠促進(jìn)肝癌細(xì)胞線粒體ROS生成。通過線粒體的ROS清除劑Mito-TEMPO對(duì)細(xì)胞中線粒體ROS進(jìn)行清除,以及線粒體鈣清除載體PV-Mito對(duì)線粒體內(nèi)的鈣離子進(jìn)行清除,發(fā)現(xiàn)MCUR1介導(dǎo)的線粒體鈣離子穩(wěn)態(tài)重塑通過促進(jìn)肝癌細(xì)胞線粒體ROS生成,而抑制細(xì)胞凋亡促進(jìn)細(xì)胞增殖。第四部分:通過檢測(cè)凋亡相關(guān)分子,增殖相關(guān)分子,P53,AKT及MDM2磷酸化的檢測(cè),證實(shí):MCUR1介導(dǎo)的線粒體鈣穩(wěn)態(tài)重塑通過ROS/AKT/MDM2途徑使P53失活促進(jìn)肝癌細(xì)胞生長。【結(jié)論】本課題研究發(fā)現(xiàn):MCUR1介導(dǎo)肝癌線粒體鈣離子攝入增強(qiáng),重塑的線粒體鈣穩(wěn)態(tài)影響ROS的生成,通過ROS/AKT/MDM2途徑使P53失活,調(diào)控肝癌的增殖凋亡,最終促進(jìn)腫瘤進(jìn)一步惡化。
[Abstract]:The steady state of mitochondrial calcium is critical to the function of the mitochondria and the effect of the cell, and the dynamic balance of the calcium ion concentration in the mitochondria is an important regulation factor of the mitochondrial respiratory function, and the imbalance of the calcium ions leads to the apoptosis of the cells. The steady-state remodeling of mitochondria is the main cause of various diseases, but it is not clear that this change plays a key role in the development of the malignant tumor. Our team first found that the newly-reported mitochondrial calcium ion uptake key regulatory molecule, MCU1, promotes the steady uptake of calcium and calcium in the liver cancer cell, and the expression level of the mitochondrial calcium ion is abnormally elevated in the liver cell of the liver cancer, The high expression of MCUR1 can promote the growth ability of the liver cancer cells by accelerating the cell proliferation and inhibiting the mitochondria-dependent endogenous cell apoptosis, and is related to the poor prognosis of the liver cancer patients. The literature reports that the calcium ion environment of mitochondria is a key factor to regulate the production of reactive oxygen ROS, and reactive oxygen ROS, as a second messenger in the cell, can activate various key signal pathways involved in the proliferation, apoptosis, metastasis and angiogenesis of tumor cells, Resulting in the occurrence of a malignant tumor. We further study that MCUR1-mediated steady-state remodeling of mitochondrial calcium results in an up-regulation of reactive oxygen ROS level in liver cancer cells, which is closely related to the downstream P53 degradation, AKT/ MDM2 signaling pathway activation. Based on this, we put forward the hypothesis that the MUR1 upregulates the steady-state remodeling of mitochondrial calcium, and by regulating the second messenger ROS in the cell, the downstream akt/ mdm2-mediated p53 degradation signal pathway is generated, and the malignant progression of the liver cancer is finally promoted. [Objective] To study whether the steady-state remodeling of mitochondrial calcium mediated by mcur1 is involved in the regulation of the growth of the liver cancer, and to explore the mechanism of the role of mcur1-mediated steady-state remodeling of the mitochondria in the control of the growth of the liver cancer. [Method] 1. The expression and correlation of mcur1 and p53 in the clinical specimens of primary liver cancer were analyzed by immunohistochemistry. The effects of mcur1 on the proliferation and apoptosis and growth of liver cancer cells were analyzed by using the method of mts to determine cell growth curve, clone formation experiment, annexin-v apoptosis detection, flow cytometry cycle detection and edu cell proliferation. The effect of mcur1 on the growth of liver cancer in vivo was analyzed using the nude mice's subcutaneous tumor-bearing experiment. The effect of mcur1 on the calcium ion level of the mitochondria of the liver cancer cells and the effect of the mitochondria on the calcium in the cytoplasm of the liver cancer cells was analyzed by using the r2005-2 and fluo-4 living cells. The effects of mcur1 on the generation of mitochondria in liver cancer cells were analyzed by using dcf and mittox dyes to dye the cells and the mitochondria. By using the western blot to detect the apoptosis-related molecules and the change of the expression of the related molecules, the mechanism of the role of mcur1-mediated steady-state remodeling of the mitochondrial calcium to promote the growth of the liver cancer cells was analyzed. [Results] The first part: Through the analysis of the clinical specimen of primary liver cancer, it was found that the expression of mcur1 in the liver cancer tissue was up-regulated and related to the bad prognosis of the liver cancer. By using the method of mts to determine the cell growth curve, the clone formation experiment, the annexin-v apoptosis test, the flow cytometry cycle detection, the edu cell proliferation, and the like, the mcur1 in the liver cancer cell is found to promote the growth of the liver cancer cell by inhibiting the cell apoptosis and accelerating the cell proliferation. By carrying out the subcutaneous tumor-bearing experiment of the nude mouse, the mcur1 is confirmed to promote the growth of the liver cancer by inhibiting the apoptosis of the liver cancer and accelerating the proliferation of the liver cancer. In the second part, the mitochondrial calcium and the cytosolic calcium were detected by rF-2 and fluo-4 staining, and it was found that mcur1 can promote the calcium ion uptake of mitochondria, increase the calcium ion concentration of the mitochondria, and reduce the buffering force of the mitochondria to the cytosolic calcium in the emergency state. It was found that mcur1 was dependent on the uptake of mitochondrial calcium in liver cancer cells. The third part: through the detection of ROS and the mitochondrial ROS, it is found that the MCU1 can promote the generation of the mitochondrial ROS in the liver cancer cells. The mitochondrial ROS in the cells was removed by the mitochondrial ROS scavenger, Mito-TEMPO, and the mitochondrial calcium removal vector PV-Mito was removed from the mitochondria, and the MUR1-mediated steady-state remodeling of the mitochondrial calcium ions was found by promoting the generation of mitochondrial ROS in the liver cancer cells, And the cell apoptosis is inhibited and the cell proliferation is promoted. The fourth part: Through the detection of the apoptosis-related molecules, the proliferation-related molecules, the P53, AKT and MDM2 phosphorylation, it was confirmed that the MUR1-mediated steady-state remodeling of the mitochondria promoted the growth of the liver cancer cells through the ROS/ AKT/ MDM2 pathway. [Conclusion] The study found that MCUR1 mediates the increase of mitochondrial calcium ion uptake in liver cancer, and the remodeling of the mitochondrial calcium homeostasis affects the production of ROS, and by means of the ROS/ AKT/ MDM2 pathway, the P53 is inactivated, the proliferation and apoptosis of the liver cancer are regulated, and the further deterioration of the tumor is promoted.
【學(xué)位授予單位】：第四軍醫(yī)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R735.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉啟帆;謝明;姜磊;;基于ROS的工業(yè)機(jī)器人運(yùn)動(dòng)規(guī)劃[J];組合機(jī)床與自動(dòng)化加工技術(shù);2017年05期

2 谷瑞環(huán);孫貽娟;馮云;孫曉溪;;玻璃化冷凍卵子中ROS產(chǎn)生和修復(fù)[J];中國優(yōu)生與遺傳雜志;2017年05期

3 趙曉娥;劉玉太;惠琦輝;葛均邦;魏強(qiáng);馬保華;;ROS誘導(dǎo)山羊卵母細(xì)胞核質(zhì)同步成熟[J];中國獸醫(yī)學(xué)報(bào);2017年07期

4 羅捷;;一種基于ROS的鼓樂機(jī)器人設(shè)計(jì)與實(shí)現(xiàn)[J];科技視界;2017年17期

5 趙輝;魏克強(qiáng);;水體銅脅迫對(duì)克氏原螯蝦血淋巴ROS和血藍(lán)蛋白含量的影響[J];科技與創(chuàng)新;2014年04期

6 王新景;劉學(xué)謙;金佳斌;鄧俠興;沈柏用;彭承宏;;膽管癌ROS融合基因的致瘤性研究[J];外科理論與實(shí)踐;2014年02期

7 張慧鋒;王月鵬;張鐸;李妍;滕利榮;;流式細(xì)胞術(shù)分析多酚類藥物姜黃素對(duì)ROS影響的方法學(xué)探討[J];時(shí)珍國醫(yī)國藥;2013年04期

8 劉明麗;張玉鈞;;游憩機(jī)會(huì)譜(ROS)在游憩資源管理中的應(yīng)用[J];世界林業(yè)研究;2008年03期

9 王冰;蔡君;杜穎;;淺析中國有效利用游憩機(jī)會(huì)譜(ROS)的途徑[J];四川林勘設(shè)計(jì);2007年03期

10 王冰;蔡君;杜穎;;淺析中國有效利用游憩機(jī)會(huì)譜(ROS)的途徑[J];河北林業(yè)科技;2007年05期

相關(guān)會(huì)議論文 前10條

1 吳承照;方家;陶聰;;城市公園游憩機(jī)會(huì)譜(ROS)與可持續(xù)性研究——以上海松鶴公園為例[A];中國風(fēng)景園林學(xué)會(huì)2011年會(huì)論文集（下冊(cè)）[C];2011年

2 余健劍;束剛;王松波;王麗娜;朱曉彤;高萍;江青艷;;下丘腦ROS對(duì)5-羥色胺抑食效應(yīng)的調(diào)控機(jī)制[A];中國畜牧獸醫(yī)學(xué)會(huì)動(dòng)物營養(yǎng)學(xué)分會(huì)第十一次全國動(dòng)物營養(yǎng)學(xué)術(shù)研討會(huì)論文集[C];2012年

3 劉俊秀;陳定邦;張基偉;周香雪;吳超;梁秀齡;李洵樺;;青霉胺絡(luò)合銅釋放ROS致神經(jīng)細(xì)胞活力下降[A];中華醫(yī)學(xué)會(huì)第十七次全國神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編（上）[C];2014年

4 肖倍倍;田欣;李明;谷蒙蒙;周平坤;尚增甫;;石墨烯量子點(diǎn)通過誘導(dǎo)ROS促進(jìn)細(xì)胞衰老[A];第八屆海峽兩岸毒理學(xué)研討會(huì)論文集[C];2015年

5 劉仲榮;楊慧蘭;;低劑量長波紫外線誘導(dǎo)人皮膚成纖維細(xì)胞適應(yīng)性反應(yīng)中ROS的變化觀察[A];美麗人生 和諧世界——中華醫(yī)學(xué)會(huì)第七次全國醫(yī)學(xué)美學(xué)與美容學(xué)術(shù)年會(huì)、中華醫(yī)學(xué)會(huì)醫(yī)學(xué)美學(xué)與美容學(xué)分會(huì)20周年慶典暨第三屆兩岸四地美容醫(yī)學(xué)學(xué)術(shù)論壇論文匯編[C];2010年

6 盛曉波;陶麗;汪思亮;韋忠紅;周梁;單云龍;陳文星;王愛云;陸茵;;蒼耳亭通過ROS依賴的細(xì)胞凋亡抑制非小細(xì)胞肺癌生長[A];中華中醫(yī)藥學(xué)會(huì)中藥實(shí)驗(yàn)藥理分會(huì)2014年學(xué)術(shù)年會(huì)論文摘要匯編[C];2014年

7 ;宰后活性氧簇(ROS)的形成對(duì)鵝肉品質(zhì)影響機(jī)制的研究[A];第六屆(2015)中國水禽發(fā)展大會(huì)論文匯編[C];2015年

8 張林;何艷玲;李清釗;袁騰;黃娜;郭菲菲;袁取祥;白玉萍;金玉蘭;劉楠;陳剛;袁揚(yáng);姚三巧;;活性氧(ROS)介導(dǎo)的肺細(xì)胞線粒體凋亡在染矽塵大鼠肺纖維化中的作用研究[A];中國職業(yè)安全健康協(xié)會(huì)2013年學(xué)術(shù)年會(huì)論文集[C];2013年

9 王丹;趙利霞;郭良宏;;化學(xué)發(fā)光法研究不同半導(dǎo)體納米材料光催化過程中ROS的動(dòng)態(tài)產(chǎn)生及其規(guī)律[A];中國化學(xué)會(huì)第30屆學(xué)術(shù)年會(huì)摘要集-第二十六分會(huì)：環(huán)境化學(xué)[C];2016年

10 董成亞;楊賓霞;王楠;林永敏;任倩;馬小彤;;mda-7/IL-24通過ROS產(chǎn)生誘導(dǎo)急性髓系白血病細(xì)胞向單核系分化[A];第13屆全國實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要[C];2011年

相關(guān)博士學(xué)位論文 前10條

1 丁寧;大黃素抑制ROS介導(dǎo)的耐藥基因表達(dá)增強(qiáng)順鉑在子宮內(nèi)膜癌的化療敏感性[D];山東大學(xué);2018年

2 左舒婷;松蘿酸通過ROS誘導(dǎo)乳腺癌細(xì)胞凋亡機(jī)制的實(shí)驗(yàn)研究[D];吉林大學(xué);2016年

3 張軍;應(yīng)用ROS抑制劑增強(qiáng)順鉑化療敏感性的實(shí)驗(yàn)研究[D];武漢大學(xué);2013年

4 陳葉珊;eNOS和ROS介導(dǎo)的辛伐他汀對(duì)腫瘤血管正�；饔玫某醪窖芯縖D];華中科技大學(xué);2012年

5 秦勇;細(xì)胞內(nèi)ROS水平改變對(duì)細(xì)胞活性及相關(guān)信號(hào)傳導(dǎo)途徑的影響[D];浙江大學(xué);2012年

6 謝濤;青藤堿通過ROS誘發(fā)內(nèi)質(zhì)網(wǎng)應(yīng)激導(dǎo)致骨肉瘤凋亡并抑制骨肉瘤增殖、侵襲、轉(zhuǎn)移[D];浙江大學(xué);2016年

7 易高;ROS介導(dǎo)的溶酶體—線粒體途徑在熱打擊誘導(dǎo)腸道損傷中的作用[D];南方醫(yī)科大學(xué);2017年

8 吳印兵;溫?zé)峄熗ㄟ^ROS誘導(dǎo)胃癌細(xì)胞自噬性死亡的實(shí)驗(yàn)研究[D];南方醫(yī)科大學(xué);2015年

9 黃齊麟;D-半乳糖誘導(dǎo)螺旋神經(jīng)節(jié)細(xì)胞ROS聚集及其與衰老和DNA甲基化的關(guān)系研究[D];華中科技大學(xué);2014年

10 盧俊;布比卡因致SH-SY5Y細(xì)胞損傷中ROS爆發(fā)及其作用靶點(diǎn)的研究[D];南方醫(yī)科大學(xué);2011年

相關(guān)碩士學(xué)位論文 前10條

1 王姣姣;MCUR1介導(dǎo)線粒體鈣穩(wěn)態(tài)重塑調(diào)控ROS產(chǎn)生促進(jìn)肝癌生長的作用機(jī)制研究[D];第四軍醫(yī)大學(xué);2016年

2 肖雄;基于ROS框架下三指機(jī)械手仿真控制[D];大連交通大學(xué);2018年

3 孫旭;ROS響應(yīng)性的納米載體聯(lián)合光動(dòng)力療法及化學(xué)療法協(xié)同增效治療甲狀腺癌[D];吉林大學(xué);2018年

4 楊愛云;低劑量納米顆粒誘導(dǎo)血管內(nèi)皮細(xì)胞產(chǎn)生ROS及其對(duì)內(nèi)皮細(xì)胞連接完整性的影響[D];北京協(xié)和醫(yī)學(xué)院;2018年

5 吉志敏;基于ROS的同位素分裝機(jī)器人運(yùn)動(dòng)規(guī)劃及控制仿真研究[D];蘭州理工大學(xué);2018年

6 何菲;PKCβ/p66Shc介導(dǎo)高水平尿素引起人臍靜脈內(nèi)皮細(xì)胞ROS和炎癥的產(chǎn)生[D];重慶醫(yī)科大學(xué);2017年

7 胡春旭;基于ROS的云機(jī)器人平臺(tái)設(shè)計(jì)與實(shí)現(xiàn)[D];華中科技大學(xué);2015年

8 劉亞楠;黃綠青霉素通過ROS介導(dǎo)HepG2細(xì)胞自噬性死亡的實(shí)驗(yàn)研究[D];大連醫(yī)科大學(xué);2015年

9 鄭梓均;基于ROS系統(tǒng)的簡(jiǎn)易服務(wù)機(jī)器人關(guān)鍵技術(shù)的研究[D];江南大學(xué);2016年

10 田亮亮;基于ROS的移動(dòng)機(jī)器人未知區(qū)域探索與環(huán)境建模[D];東北大學(xué);2015年

，

本文編號(hào)：2495786